In the Lab
Researchers discover why cancer immunotherapies often fail to finish the job.
Emerging evidence suggests that SARS-CoV-2 can drive a diverse array of immune processes, raising the risk that immunosuppressant agents that are in cl...
In the Lab
During the COVID-19 pandemic, MSK doctors and researchers are applying their knowledge about immunology toward the development of treatments.